Happy holidays, readers!

George Miller, Fiercepharmamanufacuring EditorWhen it comes to operations precision and regulatory orchestration, no one works harder than manufacturing professionals. From the receiving dock through processing, distribution through (at times) the misfortune of product recall, few pharma professionals are as visible and on the line, day in and day out, as manufacturing and operations.

Here's to you and the work you do!

Your daily efforts help save lives and improve the quality of existence for a growing proportion of the earth's 6.8 billion residents. Through your efforts, prophylactics and treatments are reaching farther and wider than ever before.

So take off some time next week, as we are at FierceMarkets.  We'll see you again on January 6, 2010. - George

Suggested Articles

Dr. Reddy’s says it has been told the FDA will not take regulatory action at its sterile formulations plant in Duvvada, Visakhapatnam.

The end is near for a GlaxoSmithKline OTC plant in Pennsylvania and its 260 employees. In fact, it has a date. 

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.